These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 39090674)
1. (S)-3-(3,4-Dihydroxybenzyl) piperazine-2,5-dione (cyclo-Gly-L-DOPA or CG-Nio-CGLD) peptide loaded in Chitosan Glutamate-Coated Niosomes as anti-Colorectal cancer activity. Piri-Gharaghie T; Ghourchian H; Rezaeizadeh G; Kabiri H; Rajaei N; Dhiaa AM; Ghajari G; Bahari R BMC Pharmacol Toxicol; 2024 Aug; 25(1):44. PubMed ID: 39090674 [TBL] [Abstract][Full Text] [Related]
2. Novel Niosome-Encapsulated 2,5-Diketopiperazine (BHPPD): Synthesis, Formulation, and Anti-breast Cancer Activity. Ghourchian H; Pecho RDC; Karimi-Dehkordi M; Mazandarani A; Ghajari G; Piri-Gharaghie T Appl Biochem Biotechnol; 2024 Jun; 196(6):3126-3147. PubMed ID: 37624507 [TBL] [Abstract][Full Text] [Related]
3. Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities. Haddadian A; Robattorki FF; Dibah H; Soheili A; Ghanbarzadeh E; Sartipnia N; Hajrasouliha S; Pasban K; Andalibi R; Ch MH; Azari A; Chitgarzadeh A; Kashtali AB; Mastali F; Noorbazargan H; Mirzaie A Sci Rep; 2022 Dec; 12(1):21938. PubMed ID: 36536030 [TBL] [Abstract][Full Text] [Related]
4. Polyvinyl Alcohol (PVA)-Based Nanoniosome for Enhanced in vitro Delivery and Anticancer Activity of Thymol. Abdihaji M; Mirzaei Chegeni M; Hadizadeh A; Farrokhzad N; Kheradmand Z; Fakhrfatemi P; Faress F; Moeinabadi-Bidgoli K; Noorbazargan H; Mostafavi E Int J Nanomedicine; 2023; 18():3459-3488. PubMed ID: 37396433 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Carum-loaded Niosomes on Breast Cancer Cells:Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay. Barani M; Mirzaei M; Torkzadeh-Mahani M; Adeli-Sardou M Sci Rep; 2019 May; 9(1):7139. PubMed ID: 31073144 [TBL] [Abstract][Full Text] [Related]
6. Chitosan -based nanoniosome for potential wound healing applications: Synergy of controlled drug release and antibacterial activity. Pourseif T; Ghafelehbashi R; Abdihaji M; Radan N; Kaffash E; Heydari M; Naseroleslami M; Mousavi-Niri N; Akbarzadeh I; Ren Q Int J Biol Macromol; 2023 Mar; 230():123185. PubMed ID: 36623618 [TBL] [Abstract][Full Text] [Related]
7. Bioresponsive gingerol-loaded alginate-coated niosomal nanoparticles for targeting intracellular bacteria and cancer cells. Pashizeh F; Mansouri A; Bazzazan S; Abdihaji M; Khaleghian M; Bazzazan S; Rezei N; Eskandari A; Mashayekhi F; Heydari M; Tavakkoli Yaraki M Int J Biol Macromol; 2024 Feb; 258(Pt 2):128957. PubMed ID: 38154726 [TBL] [Abstract][Full Text] [Related]
8. Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy. Safari Sharafshadeh M; Tafvizi F; Khodarahmi P; Ehtesham S Int J Biol Macromol; 2023 Apr; 235():123686. PubMed ID: 36801304 [TBL] [Abstract][Full Text] [Related]
9. Niosomes loading N-acetyl-L-cysteine for cancer treatment in vivo study. Mohamad EA; Ali AA; Sharaky M; El-Gebaly RH Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4339-4353. PubMed ID: 38091079 [TBL] [Abstract][Full Text] [Related]
10. 3D-printing-assisted synthesis of paclitaxel-loaded niosomes functionalized by cross-linked gelatin/alginate composite: Large-scale synthesis and in-vitro anti-cancer evaluation. Hosseini F; Mirzaei Chegeni M; Bidaki A; Zaer M; Abolhassani H; Seyedi SA; Nabipoorashrafi SA; Ashrafnia Menarbazari A; Moeinzadeh A; Farmani AR; Tavakkoli Yaraki M Int J Biol Macromol; 2023 Jul; 242(Pt 1):124697. PubMed ID: 37156313 [TBL] [Abstract][Full Text] [Related]
12. Efficient targeting of HIF-1α mediated by YC-1 and PX-12 encapsulated niosomes: potential application in colon cancer therapy. Bakand A; Moghaddam SV; Naseroleslami M; André H; Mousavi-Niri N; Alizadeh E J Biol Eng; 2023 Sep; 17(1):58. PubMed ID: 37749603 [TBL] [Abstract][Full Text] [Related]
13. In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment. Ahmadi S; Seraj M; Chiani M; Hosseini S; Bazzazan S; Akbarzadeh I; Saffar S; Mostafavi E Int J Nanomedicine; 2022; 17():6233-6255. PubMed ID: 36531115 [TBL] [Abstract][Full Text] [Related]
14. Fabrication, optimization, and characterization of pH-responsive PEGylated nanoniosomes containing gingerol for enhanced treatment of breast cancer. Asghari Lalami Z; Tafvizi F; Naseh V; Salehipour M Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3867-3886. PubMed ID: 37368028 [TBL] [Abstract][Full Text] [Related]
15. A new formulation of hydrophobin-coated niosome as a drug carrier to cancer cells. Barani M; Mirzaei M; Torkzadeh-Mahani M; Lohrasbi-Nejad A; Nematollahi MH Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110975. PubMed ID: 32487392 [TBL] [Abstract][Full Text] [Related]
16. Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells. Abdulkareem SJ; Jafari-Gharabaghlou D; Farhoudi-Sefidan-Jadid M; Salmani-Javan E; Toroghi F; Zarghami N Daru; 2024 Jun; 32(1):133-144. PubMed ID: 38168007 [TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-loaded Niosomes functionalized with gelatine and alginate as pH-responsive drug delivery system: A 3D printing approach. Zaer M; Moeinzadeh A; Abolhassani H; Rostami N; Tavakkoli Yaraki M; Seyedi SA; Nabipoorashrafi SA; Bashiri Z; Moeinabadi-Bidgoli K; Moradbeygi F; Farmani AR; Hossein-Khannazer N Int J Biol Macromol; 2023 Dec; 253(Pt 2):126808. PubMed ID: 37689301 [TBL] [Abstract][Full Text] [Related]
18. Thymol-loaded liposomes effectively induced apoptosis and decreased EGFR expression in colorectal cancer cells. Keshavarz F; Soltanshahi M; Khosravani F; Bakhshiyan F; Ghanbari A; Hassanzadeh S; Amirpour M; Ghalamfarsa G Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5157-5165. PubMed ID: 38240780 [TBL] [Abstract][Full Text] [Related]
19. Preparation, characterizations and in vitro cytotoxic activity of nickel oxide nanoparticles on HT-29 and SW620 colon cancer cell lines. Khan S; Ansari AA; Malik A; Chaudhary AA; Syed JB; Khan AA J Trace Elem Med Biol; 2019 Mar; 52():12-17. PubMed ID: 30732872 [TBL] [Abstract][Full Text] [Related]
20. Using chitosan-coated magnetite nanoparticles as a drug carrier for opioid delivery against breast cancer. Aliebrahimi S; Farnoudian-Habibi A; Heidari F; Amani A; Montazeri V; Sabz Andam S; Saber R; Alizadeh AM; Ostad SN Pharm Dev Technol; 2024 Jul; 29(6):596-603. PubMed ID: 38932720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]